abstract |
The present invention relates to chemotherapeutic agents for the treatment of viral diseases and cancer. The compounds are prodrugs of DNA polymerase inhibitors of human immunodeficiency virus (HIV), hepatitis B virus (HBV) and human immunodeficiency virus, hepatitis B virus and HIV / HCV. , Is intended to treat co-infection of HIV / HBV, HIV / HCV / HBV and HCV / HBV. |